FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200309986> ?p ?o ?g. }

• W4200309986 abstract "Abstract Background In the United States, methadone for opioid use disorder (OUD) is highly regulated. Federal agencies announced guidelines in March 2020 allowing for relaxation of take-home methadone dispensing at opioid treatment programs (OTPs) to improve treatment access and reduce COVID-19 transmission risk during the public health emergency. We explored patient perspectives at three OTPs serving rural communities on how take-home policy changes were received and implemented and how these changes impacted their addiction treatment and recovery. Methods We completed semi-structured individual qualitative interviews in 2 phases: (1) August–October 2020 and (2) November 2020–January 2021 (total n = 46), anticipating possible policy changes as the pandemic progressed. We interviewed patients with OUD enrolled at 3 rural OTPs in Oregon. Participants received varying take-home methadone allowances following the COVID-19-related policy changes. All interviews were conducted via phone, audio-recorded, and transcribed. We conducted a thematic analysis, iteratively coding transcripts, and deductively and inductively generating codes. Results The 46 participants included 50% women and 89% had Medicaid insurance. Three main themes emerged in the analysis, with no differences between study phases: (1) Adapting to changing OTP policies throughout the pandemic; (2) Recognizing the benefits, and occasional struggles, with increased take-home methadone dosing; and (3) Continuing policies and procedures post-pandemic. Participants described fears and anxieties around ongoing methadone access and safety concerns prior to OTP policy changes, but quickly adapted as protocols soon seemed “natural.” The majority of participants acknowledged significant benefits to increased take-homes independent of reducing COVID-19 infection risk including feeling “ more like a normal person,” improved recovery support, reduced time traveling, and having more time with family and for work. Looking to a post-pandemic future, participants thought some COVID-19-related safety protocols should continue that would reduce risk of other infections, make OTP settings less stressful, and result in more individualized care. Conclusions As the pandemic progressed, study participants adapted to rapidly changing OTP policies. Participants noted many unanticipated benefits to increased take-home methadone and other COVID-19 protocols including strengthened self-efficacy and recovery and reduced interpersonal conflict, with limited evidence of diversion. Patient perspectives should inform future policies to better address the ongoing overdose epidemic." @default.
• W4200309986 created "2021-12-31" @default.
• W4200309986 creator A5007915508 @default.
• W4200309986 creator A5022438468 @default.
• W4200309986 creator A5048000122 @default.
• W4200309986 creator A5060056667 @default.
• W4200309986 creator A5082885757 @default.
• W4200309986 creator A5087115421 @default.
• W4200309986 date "2021-12-01" @default.
• W4200309986 modified "2023-10-16" @default.
• W4200309986 title "Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis" @default.
• W4200309986 cites W1957890759 @default.
• W4200309986 cites W1974407154 @default.
• W4200309986 cites W1979290264 @default.
• W4200309986 cites W2008679239 @default.
• W4200309986 cites W2023468678 @default.
• W4200309986 cites W2064575747 @default.
• W4200309986 cites W2100553973 @default.
• W4200309986 cites W2107058249 @default.
• W4200309986 cites W2118239967 @default.
• W4200309986 cites W2138664283 @default.
• W4200309986 cites W215671350 @default.
• W4200309986 cites W2224997939 @default.
• W4200309986 cites W2345719282 @default.
• W4200309986 cites W2600536026 @default.
• W4200309986 cites W2811415824 @default.
• W4200309986 cites W2883535607 @default.
• W4200309986 cites W2884323094 @default.
• W4200309986 cites W2911490965 @default.
• W4200309986 cites W2912757607 @default.
• W4200309986 cites W2955994854 @default.
• W4200309986 cites W2973183464 @default.
• W4200309986 cites W2991474708 @default.
• W4200309986 cites W2993088220 @default.
• W4200309986 cites W3013151038 @default.
• W4200309986 cites W3014703200 @default.
• W4200309986 cites W3014861007 @default.
• W4200309986 cites W3014862161 @default.
• W4200309986 cites W3015487282 @default.
• W4200309986 cites W3016631191 @default.
• W4200309986 cites W3018287620 @default.
• W4200309986 cites W3020299264 @default.
• W4200309986 cites W3022725611 @default.
• W4200309986 cites W3025937663 @default.
• W4200309986 cites W3026004457 @default.
• W4200309986 cites W3040801838 @default.
• W4200309986 cites W3043408671 @default.
• W4200309986 cites W3044894494 @default.
• W4200309986 cites W3048805429 @default.
• W4200309986 cites W3091538283 @default.
• W4200309986 cites W3096553479 @default.
• W4200309986 cites W3106857395 @default.
• W4200309986 cites W3109273728 @default.
• W4200309986 cites W3110434642 @default.
• W4200309986 cites W3112597207 @default.
• W4200309986 cites W3112939818 @default.
• W4200309986 cites W3120077942 @default.
• W4200309986 cites W3120576161 @default.
• W4200309986 cites W3127726743 @default.
• W4200309986 cites W3132528429 @default.
• W4200309986 cites W3138109561 @default.
• W4200309986 cites W3158184655 @default.
• W4200309986 cites W3161856188 @default.
• W4200309986 cites W3205664554 @default.
• W4200309986 cites W4230324460 @default.
• W4200309986 doi "https://doi.org/10.1186/s13722-021-00281-3" @default.
• W4200309986 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34895346" @default.
• W4200309986 hasPublicationYear "2021" @default.
• W4200309986 type Work @default.
• W4200309986 citedByCount "23" @default.
• W4200309986 countsByYear W42003099862022 @default.
• W4200309986 countsByYear W42003099862023 @default.
• W4200309986 crossrefType "journal-article" @default.
• W4200309986 hasAuthorship W4200309986A5007915508 @default.
• W4200309986 hasAuthorship W4200309986A5022438468 @default.
• W4200309986 hasAuthorship W4200309986A5048000122 @default.
• W4200309986 hasAuthorship W4200309986A5060056667 @default.
• W4200309986 hasAuthorship W4200309986A5082885757 @default.
• W4200309986 hasAuthorship W4200309986A5087115421 @default.
• W4200309986 hasBestOaLocation W42003099861 @default.
• W4200309986 hasConcept C118552586 @default.
• W4200309986 hasConcept C126322002 @default.
• W4200309986 hasConcept C138816342 @default.
• W4200309986 hasConcept C144024400 @default.
• W4200309986 hasConcept C159110408 @default.
• W4200309986 hasConcept C160735492 @default.
• W4200309986 hasConcept C170493617 @default.
• W4200309986 hasConcept C17744445 @default.
• W4200309986 hasConcept C190248442 @default.
• W4200309986 hasConcept C199539241 @default.
• W4200309986 hasConcept C2778767360 @default.
• W4200309986 hasConcept C2779418921 @default.
• W4200309986 hasConcept C2779891985 @default.
• W4200309986 hasConcept C2781063702 @default.
• W4200309986 hasConcept C36289849 @default.
• W4200309986 hasConcept C512399662 @default.
• W4200309986 hasConcept C71924100 @default.
• W4200309986 hasConcept C74196892 @default.
• W4200309986 hasConceptScore W4200309986C118552586 @default.
• W4200309986 hasConceptScore W4200309986C126322002 @default.

• next